166 related articles for article (PubMed ID: 30003003)
21. Characterization of cationic glycoporphyrins by electrospray tandem mass spectrometry.
Silva EM; Serra VV; Ribeiro AO; Tomé JP; Domingues P; Faustino MA; Neves MG; Tomé AC; Cavaleiro JA; Ferrer-Correia AJ; Iamamoto Y; Domingues MR
Rapid Commun Mass Spectrom; 2006; 20(23):3605-11. PubMed ID: 17091537
[TBL] [Abstract][Full Text] [Related]
22. Porphyrin Nanocage-Embedded Single-Molecular Nanoparticles for Cancer Nanotheranostics.
Yu G; Cen TY; He Z; Wang SP; Wang Z; Ying XW; Li S; Jacobson O; Wang S; Wang L; Lin LS; Tian R; Zhou Z; Ni Q; Li X; Chen X
Angew Chem Int Ed Engl; 2019 Jun; 58(26):8799-8803. PubMed ID: 31034679
[TBL] [Abstract][Full Text] [Related]
23. Porphyrin-loaded nanoparticles for cancer theranostics.
Zhou Y; Liang X; Dai Z
Nanoscale; 2016 Jul; 8(25):12394-405. PubMed ID: 26730838
[TBL] [Abstract][Full Text] [Related]
24. Multimodal bacteriochlorophyll theranostic agent.
Liu TW; Chen J; Burgess L; Cao W; Shi J; Wilson BC; Zheng G
Theranostics; 2011; 1():354-62. PubMed ID: 21938263
[TBL] [Abstract][Full Text] [Related]
25. Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy.
Goel S; Ferreira CA; Chen F; Ellison PA; Siamof CM; Barnhart TE; Cai W
Adv Mater; 2018 Feb; 30(6):. PubMed ID: 29266476
[TBL] [Abstract][Full Text] [Related]
26. "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.
Luo Y; Wu H; Feng C; Xiao K; Yang X; Liu Q; Lin TY; Zhang H; Walton JH; Ajena Y; Hu Y; Lam KS; Li Y
Theranostics; 2017; 7(16):3901-3914. PubMed ID: 29109786
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of glycoconjugated porphyrin triphenylamine hybrids for targeted two-photon photodynamic therapy.
Hammerer F; Garcia G; Chen S; Poyer F; Achelle S; Fiorini-Debuisschert C; Teulade-Fichou MP; Maillard P
J Org Chem; 2014 Feb; 79(3):1406-17. PubMed ID: 24433138
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial synthesis and characterization of new asymmetric porphyrins as potential photosensitizers in photodynamic therapy.
Fagadar-Cosma E; Cseh L; Badea V; Fagadar-Cosma G; Vlascici D
Comb Chem High Throughput Screen; 2007 Jul; 10(6):466-72. PubMed ID: 17896942
[TBL] [Abstract][Full Text] [Related]
29. Fluorinated cryptophane-A and porphyrin-based theranostics for multimodal imaging-guided photodynamic therapy.
Zhang H; Yu Q; Li Y; Yang Z; Zhou X; Chen S; Jiang ZX
Chem Commun (Camb); 2020 Mar; 56(25):3617-3620. PubMed ID: 32108215
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin-mediated biomimetic synthesis of paramagnetic O
Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B
Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236
[TBL] [Abstract][Full Text] [Related]
31. Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer.
Tanaka M; Kataoka H; Mabuchi M; Sakuma S; Takahashi S; Tujii R; Akashi H; Ohi H; Yano S; Morita A; Joh T
Anticancer Res; 2011 Mar; 31(3):763-9. PubMed ID: 21498693
[TBL] [Abstract][Full Text] [Related]
32. Sugar and heavy atom effects of glycoconjugated chlorin palladium complex on photocytotoxicity.
Hirohara S; Kawasaki Y; Funasako R; Yasui N; Totani M; Alitomo H; Yuasa J; Kawai T; Oka C; Kawaichi M; Obata M; Tanihara M
Bioconjug Chem; 2012 Sep; 23(9):1881-90. PubMed ID: 22946640
[TBL] [Abstract][Full Text] [Related]
33. Conjugates of Tetrapyrrolic Macrocycles as Potential Anticancer Target-Oriented Photosensitizers.
Korolchuk AM; Zolottsev VA; Misharin AY
Top Curr Chem (Cham); 2023 Feb; 381(2):10. PubMed ID: 36826755
[TBL] [Abstract][Full Text] [Related]
34. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy using a protease-mediated theranostic agent reduces cathepsin-B activity in mouse atheromata in vivo.
Shon SM; Choi Y; Kim JY; Lee DK; Park JY; Schellingerhout D; Kim DE
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1360-5. PubMed ID: 23539220
[TBL] [Abstract][Full Text] [Related]
36. Development of PDT/PET Theranostics: Synthesis and Biological Evaluation of an (18)F-Radiolabeled Water-Soluble Porphyrin.
Entract GM; Bryden F; Domarkas J; Savoie H; Allott L; Archibald SJ; Cawthorne C; Boyle RW
Mol Pharm; 2015 Dec; 12(12):4414-23. PubMed ID: 26559906
[TBL] [Abstract][Full Text] [Related]
37. A Versatile Theranostic Nanoemulsion for Architecture-Dependent Multimodal Imaging and Dually Augmented Photodynamic Therapy.
Zhang Y; Bo S; Feng T; Qin X; Wan Y; Jiang S; Li C; Lin J; Wang T; Zhou X; Jiang ZX; Huang P
Adv Mater; 2019 May; 31(21):e1806444. PubMed ID: 30907469
[TBL] [Abstract][Full Text] [Related]
38. Tetrapyrrolic Glycosylated Macrocycles for an Application in PDT.
Momenteau M; Maillard P; De Be Linay MA; Carrez Dl; Croisy A
J Biomed Opt; 1999 Jul; 4(3):298-318. PubMed ID: 23015251
[TBL] [Abstract][Full Text] [Related]
39. Highly Efficient Photosensitizers with Far-Red/Near-Infrared Aggregation-Induced Emission for In Vitro and In Vivo Cancer Theranostics.
Wang D; Lee MMS; Shan G; Kwok RTK; Lam JWY; Su H; Cai Y; Tang BZ
Adv Mater; 2018 Sep; 30(39):e1802105. PubMed ID: 30133835
[TBL] [Abstract][Full Text] [Related]
40. Fabrication of G-quadruplex/porphyrin conjugated gold/persistent luminescence theranostic nanoprobe for imaging-guided photodynamic therapy.
Su YB; Zhao X; Chen LJ; Qian HL; Yan XP
Talanta; 2021 Oct; 233():122567. PubMed ID: 34215063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
